In 587 analysed men who have sex with men at high risk of gonorrhoea, two doses of 4CMenB did not reduce N. gonorrhoeae infection vs placebo (48.1 vs 47.8 per 100 person-years; IRR 1.01; vaccine efficacy −0.5%). Serious adverse events 4.7% vs 2.8%.
RCTn = 654
Seib et al. Meningococcal B Vaccine to Prevent Neisseria gonorrhoeae Infection